Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a-Reference-Cited by-同舟云学术

Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a

Published:2022-09 Issue:9 Volume:1868 Page:166430
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Vavougios George D.,Mavridis Theodore,Artemiadis Artemios,Krogfelt Karen A.,Hadjigeorgiou Georgios

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference71 articles.

1. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene;Magusali;Brain,2021

2. FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease;Vavougios;Brain Disord.,2021

3. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease;Vavougios;Brain Behav. Immun. Health,2021

4. Alzheimer's-like signaling in brains of COVID-19 patients;Reiken;Alzheimers Dement.,2022

5. Common peripheral immunity mechanisms in multiple sclerosis and Alzheimer's disease. Review;Rossi;Front. Immunol.,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease;Current Issues in Molecular Biology;2024-05-10

2. Periodontitis: A Plausible Modifiable Risk Factor for Neurodegenerative Diseases? A Comprehensive Review;International Journal of Molecular Sciences;2024-04-19

3. Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer’s disease;Frontiers in Human Neuroscience;2024-03-18

4. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders;Journal of Drug Delivery Science and Technology;2024-01

5. First-episode psychiatric disorder risk from SARS-CoV-2 infection, a clinical analysis with Chinese psychiatric inpatients;The Journal of Biomedical Research;2024